HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cataract Surgery in Behçet's Disease Patients One Week after Infliximab Administration.

AbstractPURPOSE:
To describe two patients with Behçet's disease who underwent cataract surgery one week after infliximab administration.
METHODS:
Patients received preoperative antibiotic therapy with 0.5% levofloxacin eye drops and 500 mg levofloxacin oral tablets, followed by cataract surgery one week after infliximab administration. We observed ocular findings following cataract surgery, phacoemulsification-aspiration, and posterior chamber intraocular lens implantation.
RESULTS:
There were no intraoperative complications. Neither ocular inflammatory attacks nor infectious complications were found in the operated eyes of both patients during follow-up.
CONCLUSION:
Administration of infliximab one week before cataract surgery is safe and effective for patients with Behçet's disease.
AuthorsTsuneaki Handa, Hinako Tsunekawa, Masahiro Zako
JournalCase reports in ophthalmology (Case Rep Ophthalmol) Vol. 2 Issue 2 Pg. 176-8 (May 2011) ISSN: 1663-2699 [Electronic] Switzerland
PMID21720532 (Publication Type: Case Reports)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: